SCHEMBL15817558

SCHEMBL15817558

O=C1CCC2C1N2Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
ELANE P08246 1/20 0.41
CTSG P08311 1/20 0.41
CMA1 P23946 1/20 0.41
CTRC Q99895 1/20 0.41
MT-CO2 P00403 2/20 0.41
ALOX5 P09917 2/20 0.41
TACR1 P25103 2/20 0.40
GAA P10253 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31295195 0.75 CYP3A4 (0.44) ALDH1A1CHRM2CHRM4CHRM5CYP3A4
SCHEMBL6949097 0.73 SIGMAR1 (0.49) ALDH1A1CHRM2CHRM4CHRM5F2
SCHEMBL5937728 0.73 L3MBTL1 (0.44) ALDH1A1TACR1GAASIGMAR1DDB1
SCHEMBL10455603 0.73 L3MBTL1 (0.44) ALDH1A1TACR1GAASIGMAR1DDB1
SCHEMBL5937718 0.73 L3MBTL1 (0.44) ALDH1A1TACR1GAASIGMAR1DDB1
SCHEMBL5939054 0.72 SIGMAR1 (0.50) ALDH1A1MT-CO2ALOX5SIGMAR1
SCHEMBL5939045 0.72 SIGMAR1 (0.50) ALDH1A1MT-CO2ALOX5SIGMAR1
SCHEMBL13772148 0.71 ALDH1A1 (0.53) ALDH1A1CHRM2CHRM4CHRM5CYP3A4
SCHEMBL4048126 0.71 ALDH1A1 (0.53) ALDH1A1CHRM2CHRM4CHRM5CYP3A4
SCHEMBL10500589 0.71 CHRM2 (0.52) ALDH1A1CHRM2CHRM4CHRM5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935263-B1 SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS MERCK SHARP & DOHME (US) 2018-12-05 EP disclosed
EP-2935263-A1 SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-10-28 EP disclosed
US-8962611-B2 Substituted imidazopyridines as HDM2 inhibitors MERCK SHARP & DOHME CORP. (US) 2015-02-24 US disclosed
US-20140357618-A1 SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS MERCK SHARP & DOHME LLC 2014-12-04 US disclosed
US-8846657-B2 Substituted imidazopyridines as HDM2 inhibitors MERCK SHARP & DOHME CORP. (US) 2014-09-30 US disclosed
US-20140179680-A1 Substituted Imidazopyridines as HDM2 Inhibitors MERCK SHARP & DOHME LLC 2014-06-26 US disclosed
WO-2014100065-A1 SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179680-A1 Substituted Imidazopyridines as HDM2 Inhibitors DDX21, ING2, MDM2 ALDH1A1 2681/4885CHRM2 4873/4885CHRM4 4882/4885
US-20140357618-A1 SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS DDX21, ING2, MDM2 ALDH1A1 2681/4885CHRM2 4873/4885CHRM4 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.